Protocol Ledger

NCT06134492 · Phase III · RECRUITING

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL

Interventional Phase III clinical trial protocol NCT06134492 sponsored by Jena University Hospital in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-02-20 Enrollment: 616 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06134492
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)616 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06134492
Protocol FieldVerified Registry Value
NCT IdentifierNCT06134492
Consolidated Lead SponsorJena University Hospital
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment616 participants (ESTIMATED)
Registered Start Date2024-02-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06134492
Hospital Research SiteLocationSite Profile
Universitätsklinikum FreiburgFreiburg im Breisgau, GermanyOpen Hospital Dossier ->
Universitätsklinikum HeidelbergHeidelberg, GermanyOpen Hospital Dossier ->
Universitätsklinikum TübingenTübingen, GermanyOpen Hospital Dossier ->
Universitätsklinikum Hamburg-EppendorfHamburg, GermanyOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI